Takeda Subsidiary Lands HHS Contract to Develop, Test Zika Vaccine
A U.S. subsidiary of Takeda Group has received an initial $19.8 million contract from the Department of Health and Human Services to develop and test a Zika virus vaccine over the next 18 months. HHS’ Biomedical Advanced Research and Development Authority will provide funds to help Takeda Vaccines complete process development and preclinical tests of the company’s vaccine candidate against the virus, HHS […] More